Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TETRAHYDROCANNALBINOL DIRECT BLOOD KIT

K-Number: K791649 · 1979-10-11

ApplicantImmunalysis Corporation
Decision Date1979-10-11
Product CodeLAT
Advisory CommitteeTX
DecisionSubstantially Equivalent

Device Summary

TETRAHYDROCANNALBINOL DIRECT BLOOD KIT is the device name listed in this FDA 510(k) record. The listed applicant is Immunalysis Corporation. It received FDA 510(k) clearance on 1979-10-11 under 510(k) number K791649. The device is classified under product code LAT. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TETRAHYDROCANNALBINOL DIRECT BLOOD KIT?

TETRAHYDROCANNALBINOL DIRECT BLOOD KIT is a medical device that received FDA 510(k) clearance on 1979-10-11. The listed applicant is Immunalysis Corporation. The 510(k) number is K791649.

When did TETRAHYDROCANNALBINOL DIRECT BLOOD KIT receive FDA 510(k) clearance?

TETRAHYDROCANNALBINOL DIRECT BLOOD KIT received FDA 510(k) clearance on 1979-10-11, under 510(k) number K791649.

Who is the listed applicant for TETRAHYDROCANNALBINOL DIRECT BLOOD KIT?

The FDA 510(k) record lists Immunalysis Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for TETRAHYDROCANNALBINOL DIRECT BLOOD KIT?

The FDA product code for TETRAHYDROCANNALBINOL DIRECT BLOOD KIT is LAT.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Immunalysis Corporation as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K252520SEFRIA™ Hydrocodone Oral FluidK232898Quantisal™ Oral Fluid Collection DeviceK223781Quantisal™ II Oral Fluid Collection DeviceK203647SEFRIA Methamphetamine Oral Fluid Enzyme ImmunoassayK203564SEFRIA Oxycodone Oral Fluid Enzyme ImmunoassayK203489SEFRIA PCP Oral Fluid Enzyme Immunoassay

View all 40 devices →

Related Devices (Code: LAT)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K011426PSYCHEMEDICS RIA CANNABINOID ASSAYPsychemedics Corp.K961620ABISCREEN ONLINE FOR CANNABINOIDS - ES 50/100Roche Diagnostic Systems, Inc.K936135SUDORMED SWEAT PATCH SPECIMEN CONTAINER FOR COLLECTION OF MARIJUANA IN PERSPIRATIONSudormed, Inc.K914507DOUBLE ANTIBODY CANNABIONOIDS/QUAIL DETER IN URINEDiagnostic Products Corp.K913414ABUSCREEN(R) ONLINE(TM) FOR THC(50/100)(100TEST KTRoche Diagnostic Systems, Inc.K913865URINE THC DIRECT RIA KIT (I-125)Immunalysis Corporation

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑